Literature DB >> 9499386

SV40 large T antigen is modified with O-linked N-acetylglucosamine but not with other forms of glycosylation.

L Medina1, K Grove, R S Haltiwanger.   

Abstract

SV40 large T antigen has been reported to be modified with several different sugars including N-acetylglucosamine, galactose, and mannose. In this report we have reexamined the glycosylation of T antigen and found that while we could detect modification with N-acetylglucosamine, we could not detect any other sugars on the protein. Surprisingly, even though [3H]galactose could be metabolically incorporated into the protein, analysis showed that all of the radioactivity in T antigen had been converted to other species. The N-acetylglucosamine was demonstrated to be linked to the protein in the form of O-linked N-acetylglucosamine, the best characterized form of nuclear and cytoplasmic glycosylation in mammalian systems. We have localized the major site of glycosylation to the amino terminal portion of the molecule. Analysis of mutated T antigen where serines 111/112 were substituted with alanine suggest that these residues constitute a glycosylation site on the protein. These two serines fall within a typical O-linked N-acetylglucosamine glycosylation site (PSS) and are also known to be phosphorylated. Thus, it is likely that competition between phosphorylation and glycosylation occurs at this site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499386     DOI: 10.1093/glycob/8.4.383

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  16 in total

1.  Detection and analysis of proteins modified by O-linked N-acetylglucosamine.

Authors:  Natasha E Zachara; Keith Vosseller; Gerald W Hart
Journal:  Curr Protoc Protein Sci       Date:  2011-11

2.  mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.

Authors:  Valerie L Sodi; Sakina Khaku; Raisa Krutilina; Luciana P Schwab; David J Vocadlo; Tiffany N Seagroves; Mauricio J Reginato
Journal:  Mol Cancer Res       Date:  2015-01-30       Impact factor: 5.852

3.  Detection and analysis of proteins modified by O-linked N-acetylglucosamine.

Authors:  Natasha E Zachara; Keith Vosseller; Gerald W Hart
Journal:  Curr Protoc Mol Biol       Date:  2011-07

Review 4.  O-GlcNAc and the cardiovascular system.

Authors:  Sujith Dassanayaka; Steven P Jones
Journal:  Pharmacol Ther       Date:  2013-11-25       Impact factor: 12.310

5.  Effect of Phosphorylation and O-GlcNAcylation on Proline-Rich Domains of Tau.

Authors:  Lata Rani; Jeetain Mittal; Sairam S Mallajosyula
Journal:  J Phys Chem B       Date:  2020-03-02       Impact factor: 2.991

6.  Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags.

Authors:  Jessica E Rexach; Claude J Rogers; Seok-Ho Yu; Jifang Tao; Yi E Sun; Linda C Hsieh-Wilson
Journal:  Nat Chem Biol       Date:  2010-07-25       Impact factor: 15.040

7.  AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation.

Authors:  Win D Cheung; Gerald W Hart
Journal:  J Biol Chem       Date:  2008-03-19       Impact factor: 5.157

Review 8.  Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.

Authors:  Ronald J Copeland; John W Bullen; Gerald W Hart
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-04-29       Impact factor: 4.310

9.  Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation.

Authors:  Alexander Golks; Thi-Thanh Thao Tran; Jean Francois Goetschy; Danilo Guerini
Journal:  EMBO J       Date:  2007-09-20       Impact factor: 11.598

10.  O-GlcNAc modification of the coat protein of the potyvirus Plum pox virus enhances viral infection.

Authors:  José de Jesús Pérez; Namrata D Udeshi; Jeffrey Shabanowitz; Sergio Ciordia; Silvia Juárez; Cheryl L Scott; Neil E Olszewski; Donald F Hunt; Juan Antonio García
Journal:  Virology       Date:  2013-04-29       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.